We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $2.04B
1-Year Est. Return 94.26%
This Fund
S&P 500
This Quarter Est. Return
+21.35%
1 Year Est. Return
+94.26%
3 Year Est. Return
+310.51%
5 Year Est. Return
+306.13%
10 Year Est. Return
+3,783.92%
AUM
$2.04B
AUM Growth
+$120M
Cap. Flow
-$149M
Cap. Flow %
-7.33%
Top 10 Hldgs %
47.27%
Holding
257
New
21
Increased
32
Reduced
47
Closed
104

Top Buys

Rank Stock Value
1
U icon
Unity
U
+$16.4M
2
TRAX
First Tracks Biotherapeutics
TRAX
+$14M
3
SE icon
Sea Limited
SE
+$11.9M
4
NU icon
Nu Holdings
NU
+$10.1M
5
GOSS icon
Gossamer Bio
GOSS
+$9.54M

Top Sells

Rank Stock Value
1
ASTH icon
Astrana Health
ASTH
+$17.6M
2
LLY icon
Eli Lilly
LLY
+$15.3M
3
GXO icon
GXO Logistics
GXO
+$14.8M
4
FOLD
Amicus Therapeutics
FOLD
+$11.2M
5
APLS
Apellis Pharmaceuticals
APLS
+$10.1M

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.9%
2 Healthcare 24.5%
3 Financials 7.3%
4 Consumer Discretionary 7.28%
5 Technology 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEN icon
51
Lennar Class A
LEN
$19.5B
$9.05M 0.44%
100,000
+95,000
+1,900% +$8.49M
LEN icon
52
PUT
Lennar Class A
LEN
$19.5B
$9.05M 0.44%
100,000
-50,000
-33% -$4.47M
B
53
Barrick Mining
B
$73.4B
$8.89M 0.44%
242,000
-158,000
-40% -$6.48M
LXEO icon
54
Lexeo Therapeutics
LXEO
$368M
$8.73M 0.43%
1,875,000
+675,000
+56% +$3.65M
VTOL icon
55
Bristow Group
VTOL
$1.28B
$8.47M 0.42%
205,000
+19,000
+10% +$851K
ICLR icon
56
Icon
ICLR
$12.3B
$8.34M 0.41%
48,000
-14,000
-23% -$1.78M
BLDR icon
57
Builders FirstSource
BLDR
$6.61B
$8.05M 0.4%
90,000
+10,000
+13% +$799K
STTK icon
58
Shattuck Labs
STTK
$635M
$8.03M 0.39%
1,157,216
+357,216
+45% +$2.23M
HIMS icon
59
PUT
Hims & Hers Health
HIMS
$6.51B
$7.63M 0.37%
220,000
– –
ATEX icon
60
Anterix
ATEX
$1.65B
$6.79M 0.33%
66,000
+20,000
+43% +$1.17M
RNAC icon
61
Cartesian Therapeutics
RNAC
$263M
$6.77M 0.33%
650,000
+320,000
+97% +$2.37M
NE icon
62
Noble Corp
NE
$7.26B
$6.53M 0.32%
175,000
+25,000
+17% +$1.2M
GOSS icon
63
Gossamer Bio
GOSS
$78.1M
$6.45M 0.32%
39,198,868
+34,198,868
+684% +$9.54M
ALEC icon
64
Alector
ALEC
$253M
$6.43M 0.32%
3,200,000
– –
DDI
65
DoubleDown Interactive
DDI
$630M
$6.31M 0.31%
550,000
+35,344
+7% +$380K
AIV
66
Aimco
AIV
$357M
$6.24M 0.31%
2,100,000
+650,000
+45% +$2.49M
MCO icon
67
Moody's
MCO
$82.2B
$4.98M 0.24%
11,000
– –
SPGI icon
68
S&P Global
SPGI
$123B
$4.92M 0.24%
12,087
– –
ERII icon
69
Energy Recovery
ERII
$377M
$4.78M 0.23%
530,000
-20,000
-4% -$190K
AMZN icon
70
Amazon
AMZN
$2.72T
$4.53M 0.22%
19,000
-7,500
-28% -$1.88M
BNED icon
71
Barnes & Noble Education
BNED
$375M
$4.38M 0.22%
349,046
-30,954
-8% -$323K
RNA
72
Atrium Therapeutics
RNA
$180M
$4.04M 0.2%
300,000
– –
WW
73
WW International
WW
$149M
$3.87M 0.19%
242,017
+92,017
+61% +$1.23M
SAAQ
74
Space Asset Acquisition Corp
SAAQ
$316M
$3.83M 0.19%
375,000
– –
PURR
75
Hyperliquid Strategies Inc
PURR
$2.38B
$3.78M 0.19%
480,000
-370,000
-44% -$2.74M
1 2
3
4 5

Similar funds

SFI
Siemens Fonds Invest Munich, Germany $2.04B AUM 40.78% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $2.04B AUM 33.06% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
C
Certuity North Palm Beach, Florida $2.03B AUM 88.59% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
JCM
Jacobi Capital Management Pittston, Pennsylvania $2.04B AUM 26.26% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return

683 Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, 683 Capital Management held 257 positions worth $2.04B, up 6.3% from $1.92B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

683 Capital Management withdrew a net $149M in Q2 2026, closing 104 positions and reducing 47 holdings. Its most notable exit was Eli Lilly, an estimated $15.3M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, up from 47% a quarter earlier, followed by Healthcare and Financials.

Against the trend, 683 Capital Management opened a new position in Unity worth $17.6M.

  • 683 Capital Management's largest Q2 2026 buy was Unity: 615,000 shares worth $17.6M.
  • 683 Capital Management added most to Gossamer Bio in Q2 2026, an estimated $9.54M increase.
  • 683 Capital Management's biggest Q2 2026 reduction was Astrana Health, cutting an estimated $17.6M.
  • 683 Capital Management fully exited Eli Lilly in Q2 2026, selling an estimated $15.3M.
  • 683 Capital Management's ten largest holdings make up 47% of its $2.04B portfolio in Q2 2026.
  • 683 Capital Management opened 21 new positions and closed 104 in Q2 2026.
  • 683 Capital Management's portfolio value rose 6.3% quarter-over-quarter to $2.04B.

Based on 683 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.